| Financial Year |
March 31 2023 |
| Monetary Funds |
2,068,792,323.86 |
| Held-for-trading Financial Assets |
470,233,769.58 |
| Notes Receivable |
2,157,276.30 |
| Accounts Receivable |
134,952,732.85 |
| Advances to Suppliers |
88,064,994.79 |
| Other Receivables |
51,198,150.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
522,557,764.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
309,963,615.24 |
| Total Current Assets |
4,271,803,977.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
708,407,029.90 |
| Investment Properties |
-- |
| Fixed Assetes |
4,371,318,596.74 |
| Under-construction Projects |
5,761,266,447.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
802,912,620.63 |
| R&D expenses |
-- |
| Goodwill |
45,537,770.99 |
| Long-Term Deferred and Prepaid Expenses |
43,747,683.66 |
| Deferred Income Tax Assets |
386,258,359.76 |
| Other Non-Current Assets |
702,324,499.59 |
| Sub-Total of Non-Current Assets |
13,971,791,062.66 |
| Total Assets |
18,243,595,039.82 |
| Short-Term Loans |
1,616,256,756.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
113,282,916.79 |
| Accounts Payable |
814,282,888.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,975,281.02 |
| Taxes Payable |
39,788,626.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
403,838,614.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,228,551,821.31 |
| Other Current Liabilities |
235,850,298.98 |
| Sub-Total of Current Liabilities |
4,646,978,457.60 |
| Long-term Loans |
1,948,300,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
89,589,548.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,139,680,238.95 |
| Total Liabilities |
6,786,658,696.55 |
| Paid-In Capital(Or Share Stock) |
2,058,036,276.00 |
| Capital Surplus |
2,898,671,464.38 |
| Surplus Reserve |
821,118,668.86 |
| LESS:Treasury Stock |
283,413,311.28 |
| Undistributed Profits |
5,656,972,092.24 |
| Minority Stockholder's Interest |
96,684,543.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,360,251,799.64 |
| Owner's Equity（Stockholder's Equity） |
11,456,936,343.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,243,595,039.82 |
